All procedures involving the use of human embryonic stem cells can not be patented
This is stated in a preliminary ruling, the Court issued a ruling. As early as 1991 a scholar going to patent a method for obtaining neural cells from embryos to treat diseases of the brain and spinal cord. Take advantage of it, he could not because of two decades of legal debate.
They can not develop into a human being. Nevertheless, to ignore the existence of an embryo as a source of such cells, he said, is impossible. Otherwise, it will lead to the creation and destruction of human embryos on an industrial scale, which contradicts the ethics of modern society.
The preliminary conclusion will now be considered the thirteen judges of the Grand Chamber of the Court. The final decision is expected within several months. It will not
can only work with imported materials created no later than May 2007. Such cells can be converted only in certain organs but not in a full-fledged human.
EU legislation concerning patents on biotechnology is very vaguely formulated questions related to hESC. The drafters of the rules can be expressed in clear, even when dealing with cells derived from spare embryos created for in vitro fertilization and still be destroyed.
12
0 comments:
Post a Comment